119 related articles for article (PubMed ID: 38407382)
1. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
Barcelos RR; Sugarbaker E; Kennedy KF; McAllister M; Kim S; Herrera-Zamora J; Leo R; Swanson S; Ugalde Figueroa P
Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38407382
[TBL] [Abstract][Full Text] [Related]
2. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
[No Abstract] [Full Text] [Related]
3. Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
Decaluwé H; Stanzi A; Dooms C; Fieuws S; Coosemans W; Depypere L; Deroose CM; Dewever W; Nafteux P; Peeters S; Van Veer H; Verbeken E; Van Raemdonck D; Moons J; De Leyn P;
Eur J Cardiothorac Surg; 2016 Jul; 50(1):110-7. PubMed ID: 26819286
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract][Full Text] [Related]
5. Surgeon experience does not influence nodal upstaging during vats lobectomy: Results from a large prospective national database.
Chiappetta M; Lococo F; Sperduti I; Tabacco D; Sassorossi C; Curcio C; Crisci R; Meacci E; Rea F; Margaritora S;
Surgery; 2024 May; 175(5):1408-1415. PubMed ID: 38302325
[TBL] [Abstract][Full Text] [Related]
6. Consolidation/Tumor Ratio on Chest Computed Tomography as Predictor of Postoperative Nodal Upstaging in Clinical T1N0 Lung Cancer.
Moon Y; Park JK; Lee KY; Namkoong M; Ahn S
World J Surg; 2018 Sep; 42(9):2872-2878. PubMed ID: 29450699
[TBL] [Abstract][Full Text] [Related]
7. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509
[TBL] [Abstract][Full Text] [Related]
8. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
[TBL] [Abstract][Full Text] [Related]
9. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
10. Different nodal upstaging rates and prognoses for patients with clinical T1N0M0 lung adenocarcinoma classified according to the presence of solid components in the lung and mediastinal windows.
Zhang C; Luan K; Li S; Wang Z; Chen S; Zhang W; Zhao C; Liu A; Jiao W
J Thorac Dis; 2023 Jul; 15(7):3612-3626. PubMed ID: 37559610
[TBL] [Abstract][Full Text] [Related]
11. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
12. Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer†.
Decaluwé H; Petersen RH; Brunelli A; Pompili C; Seguin-Givelet A; Gust L; Aigner C; Falcoz PE; Rinieri P; Augustin F; Sokolow Y; Verhagen A; Depypere L; Papagiannopoulos K; Gossot D; D'Journo XB; Guerrera F; Baste JM; Schmid T; Stanzi A; Van Raemdonck D; Bardet J; Thomas PA; Massard G; Fieuws S; Moons J; Dooms C; De Leyn P; Hansen HJ;
Eur J Cardiothorac Surg; 2018 Feb; 53(2):359-365. PubMed ID: 29029062
[TBL] [Abstract][Full Text] [Related]
13. Impact of waiting times on tumour growth and pathologic upstaging in patients with non-small cell lung cancer having lung resection.
Bhat I; Okiror L; Nair A; Billè A
Tumori; 2021 Aug; 107(4):329-334. PubMed ID: 33021465
[TBL] [Abstract][Full Text] [Related]
14. The progression of non-small cell lung cancer from diagnosis to surgery.
McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
[TBL] [Abstract][Full Text] [Related]
15. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
[TBL] [Abstract][Full Text] [Related]
17. Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.
Shiono S; Abiko M; Sato T
Eur J Cardiothorac Surg; 2013 Jan; 43(1):e7-e12. PubMed ID: 23129358
[TBL] [Abstract][Full Text] [Related]
18. Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography.
Shiono S; Yanagawa N; Abiko M; Sato T
Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):637-43. PubMed ID: 24994703
[TBL] [Abstract][Full Text] [Related]
19. Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.
Hattori A; Takamochi K; Matsunaga T; Oh S; Suzuki K
Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):18-24. PubMed ID: 26486132
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in staging early lung cancer: a randomized trial.
Maziak DE; Darling GE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Miller JD; Gu CS; Cline KJ; Evans WK; Levine MN
Ann Intern Med; 2009 Aug; 151(4):221-8, W-48. PubMed ID: 19581636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
